NO994947L - Nye cykliske forbindelser som har en cykloalkylenkjede, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem - Google Patents

Nye cykliske forbindelser som har en cykloalkylenkjede, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem

Info

Publication number: NO994947L
Authority: NO; Norway
Prior art keywords: alkyl; optionally substituted; halo; aryl; substituted
Prior art date: 1998-10-12

Application number

NO994947A

Other languages

English (en)

Other versions

NO327076B1 (no

NO994947D0 (no

Inventor

Michel Langlois

Monique Mathe-Allainmat

Marie Lefas-Le Gall

Caroline Bennejean

Pierre Renard

Philippe Delagrange

Original Assignee

Adir

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-12

Filing date

1999-10-11

Publication date

2000-04-13

1999-10-11 Application filed by Adir filed Critical Adir

1999-10-11 Publication of NO994947D0 publication Critical patent/NO994947D0/no

2000-04-13 Publication of NO994947L publication Critical patent/NO994947L/no

2009-04-20 Publication of NO327076B1 publication Critical patent/NO327076B1/no

Links

150000001923 cyclic compounds Chemical class 0.000 title 1
125000002993 cycloalkylene group Chemical group 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 11
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 abstract 6
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 6
125000001475 halogen functional group Chemical group 0.000 abstract 6
125000003545 alkoxy group Chemical group 0.000 abstract 4
125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 4
125000003118 aryl group Chemical group 0.000 abstract 4
125000006684 polyhaloalkyl group Polymers 0.000 abstract 4
125000000392 cycloalkenyl group Chemical group 0.000 abstract 3
125000001624 naphthyl group Chemical group 0.000 abstract 3
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 3
241000689227 Cora <basidiomycete fungus> Species 0.000 abstract 2
UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 abstract 2
JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 2
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 2
125000004122 cyclic group Chemical group 0.000 abstract 2
ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 abstract 2
125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 2
125000001072 heteroaryl group Chemical group 0.000 abstract 2
125000001041 indolyl group Chemical group 0.000 abstract 2
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
-1 COORa Chemical group 0.000 abstract 1
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
125000003342 alkenyl group Chemical group 0.000 abstract 1
125000000304 alkynyl group Chemical group 0.000 abstract 1
235000010290 biphenyl Nutrition 0.000 abstract 1
239000004305 biphenyl Substances 0.000 abstract 1
239000004202 carbamide Substances 0.000 abstract 1
125000000753 cycloalkyl group Chemical group 0.000 abstract 1
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
125000002950 monocyclic group Chemical group 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
125000003367 polycyclic group Chemical group 0.000 abstract 1
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
229920006395 saturated elastomer Polymers 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/23—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a ring other than a six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/58—Radicals substituted by nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Endocrinology (AREA)
Obesity (AREA)
Hematology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Reproductive Health (AREA)
Emergency Medicine (AREA)
Child & Adolescent Psychology (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Anesthesiology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Furan Compounds (AREA)
Pyrane Compounds (AREA)

NO19994947A 1998-10-12 1999-10-11 Nye cykliske forbindelser som har en cykloalkylenkjede, fremgangsmate ved deres fremstilling og farmasoytiske sammensetninger inneholdende dem NO327076B1 (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9812738A FR2784375B1 (fr)	1998-10-12	1998-10-12	Nouveaux derives cycliques a chaine cycloalkylenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (3)

Publication Number	Publication Date
NO994947D0 NO994947D0 (no)	1999-10-11
NO994947L true NO994947L (no)	2000-04-13
NO327076B1 NO327076B1 (no)	2009-04-20

Family

ID=9531433

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19994947A NO327076B1 (no)	1998-10-12	1999-10-11	Nye cykliske forbindelser som har en cykloalkylenkjede, fremgangsmate ved deres fremstilling og farmasoytiske sammensetninger inneholdende dem

Country Status (21)

Country	Link
US (1)	US6583319B1 (no)
EP (1)	EP0994102B1 (no)
JP (2)	JP3361490B2 (no)
KR (1)	KR100439602B1 (no)
CN (1)	CN1216856C (no)
AT (1)	ATE234808T1 (no)
AU (1)	AU755115B2 (no)
BR (1)	BR9904951B1 (no)
CA (1)	CA2284446C (no)
DE (1)	DE69906000T2 (no)
DK (1)	DK0994102T3 (no)
EA (1)	EA002818B1 (no)
ES (1)	ES2195529T3 (no)
FR (1)	FR2784375B1 (no)
HU (1)	HUP9903514A3 (no)
NO (1)	NO327076B1 (no)
NZ (1)	NZ500193A (no)
PL (1)	PL195667B1 (no)
PT (1)	PT994102E (no)
SI (1)	SI0994102T1 (no)
ZA (1)	ZA996439B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR028110A1 (es) *	2000-06-02	2003-04-23	Astrazeneca Ab	Nuevo proceso
FR2814165B1 (fr)	2000-09-15	2002-11-22	Adir	Nouveaux derives biphenyles substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
TW201412738A (zh) *	2006-01-17	2014-04-01	Vertex Pharma	適合作為傑納斯激酶（ｊａｎｕｓｋｉｎａｓｅ）抑制劑之氮雜吲哚
KR101380139B1 (ko)	2006-05-18	2014-04-01	신젠타 리미티드	신규한 살미생물제
FR2903102B1 (fr) *	2006-06-30	2010-08-13	Servier Lab	Nouveaux derives naphtaleniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2918369B1 (fr) *	2007-07-02	2009-08-28	Servier Lab	Nouveaux derives naphtaleniques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2919606B1 (fr) *	2007-08-03	2010-09-17	Servier Lab	Nouveau procede de synthese du (7-methoxy-1-naphtyl) acetonitrile et application a la synthese de l'agomelatine.
MX2011001062A (es) *	2008-07-30	2011-03-24	Ferrer Int	Compuestos de 1,6-dihidro-2h-3-oxa-6-aza-as-indaceno.
FR2934859B1 (fr) *	2008-08-05	2010-08-13	Servier Lab	Nouveau procede de synthese de l'agomelatine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5236953A (en) *	1982-04-14	1993-08-17	Imperial Chemical Industries Plc	Alkene, alkyne or cycloalkylene derivatives
FR2729147A1 (fr) *	1995-01-11	1996-07-12	Adir	Nouveaux composes (hetero) cycliques alkyles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2734816B1 (fr) *	1995-05-31	1997-07-04	Adir	Nouveaux aryl (alkyl) propylamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2734814B1 (fr) *	1995-05-31	1997-07-04	Adir	Nouveaux composes alkoxy-aryles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2734815B1 (fr) *	1995-05-31	1997-07-04	Adir	Nouveaux composes arylalkyl (thio) carboxamides, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
CA2176854A1 (en) *	1995-06-07	1996-12-08	Daniel J. Keavy	N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
FR2737725B1 (fr) *	1995-08-08	1997-10-31	Valentonine	Nouveaux derives acyles de la melatonine et d'analogues melatoninergiques, leur procede de preparation et leur utilisation en tant que medicament

1998
- 1998-10-12 FR FR9812738A patent/FR2784375B1/fr not_active Expired - Fee Related
1999
- 1999-10-05 CA CA002284446A patent/CA2284446C/fr not_active Expired - Fee Related
- 1999-10-06 JP JP28575699A patent/JP3361490B2/ja not_active Expired - Fee Related
- 1999-10-11 EA EA199900819A patent/EA002818B1/ru not_active IP Right Cessation
- 1999-10-11 BR BRPI9904951-1A patent/BR9904951B1/pt not_active IP Right Cessation
- 1999-10-11 NZ NZ500193A patent/NZ500193A/xx not_active IP Right Cessation
- 1999-10-11 NO NO19994947A patent/NO327076B1/no not_active IP Right Cessation
- 1999-10-12 PL PL335954A patent/PL195667B1/pl not_active IP Right Cessation
- 1999-10-12 SI SI9930237T patent/SI0994102T1/xx unknown
- 1999-10-12 AT AT99402495T patent/ATE234808T1/de active
- 1999-10-12 AU AU53621/99A patent/AU755115B2/en not_active Ceased
- 1999-10-12 ZA ZA9906439A patent/ZA996439B/xx unknown
- 1999-10-12 DE DE69906000T patent/DE69906000T2/de not_active Expired - Lifetime
- 1999-10-12 DK DK99402495T patent/DK0994102T3/da active
- 1999-10-12 US US09/415,648 patent/US6583319B1/en not_active Expired - Fee Related
- 1999-10-12 EP EP99402495A patent/EP0994102B1/fr not_active Expired - Lifetime
- 1999-10-12 HU HU9903514A patent/HUP9903514A3/hu unknown
- 1999-10-12 KR KR10-1999-0044005A patent/KR100439602B1/ko not_active Expired - Fee Related
- 1999-10-12 PT PT99402495T patent/PT994102E/pt unknown
- 1999-10-12 ES ES99402495T patent/ES2195529T3/es not_active Expired - Lifetime
- 1999-10-12 CN CN99121093XA patent/CN1216856C/zh not_active Expired - Fee Related
2002
- 2002-07-05 JP JP2002196850A patent/JP2003089639A/ja active Pending

Also Published As

Publication number	Publication date
CA2284446A1 (fr)	2000-04-12
DE69906000D1 (de)	2003-04-24
CN1216856C (zh)	2005-08-31
PL335954A1 (en)	2000-04-25
HU9903514D0 (en)	1999-12-28
EA199900819A2 (ru)	2000-04-24
SI0994102T1 (en)	2003-06-30
NO327076B1 (no)	2009-04-20
HUP9903514A2 (hu)	2000-05-28
BR9904951A (pt)	2000-09-12
FR2784375B1 (fr)	2000-11-24
AU5362199A (en)	2000-04-13
HUP9903514A3 (en)	2001-12-28
ATE234808T1 (de)	2003-04-15
AU755115B2 (en)	2002-12-05
DK0994102T3 (da)	2003-06-23
ES2195529T3 (es)	2003-12-01
KR100439602B1 (ko)	2004-07-12
EP0994102B1 (fr)	2003-03-19
JP2000136173A (ja)	2000-05-16
EA002818B1 (ru)	2002-10-31
US6583319B1 (en)	2003-06-24
ZA996439B (en)	2000-04-12
CN1250771A (zh)	2000-04-19
NZ500193A (en)	2001-01-26
KR20000029002A (ko)	2000-05-25
DE69906000T2 (de)	2004-01-08
EA199900819A3 (ru)	2000-08-28
NO994947D0 (no)	1999-10-11
PL195667B1 (pl)	2007-10-31
PT994102E (pt)	2003-06-30
CA2284446C (fr)	2003-12-02
HK1026201A1 (en)	2000-12-08
JP2003089639A (ja)	2003-03-28
JP3361490B2 (ja)	2003-01-07
BR9904951B1 (pt)	2010-11-16
FR2784375A1 (fr)	2000-04-14
EP0994102A1 (fr)	2000-04-19

Legal Events

Date	Code	Title	Description
2013-05-27	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
NO994947D0 (no)	1999-10-11	Nye cykliske forbindelser som har en cykloalkylenkjede, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
EA200400944A1 (ru)	2005-04-28	Замещенные производные тетрациклина, фармацевтическая композиция и способ лечения субъекта с их использованием
FI98367B (fi)	1997-02-28	Menetelmä uusien terapeuttisesti käyttökelpoisten trisyklisten, typpipitoisten yhdisteiden valmistamiseksi
FI104045B1 (fi)	1999-11-15	Menetelmä ruoansulatuskanavan ulkopuolisesti annettavan antibakteerisen koostumuksen valmistamiseksi
YU21590A (sh)	1993-05-28	Derivati benzokondenziranih, n vsebujočih heterociklov in postopek za njihovo pripravo
BR1100061A (pt)	2000-04-18	Composto, processo para a preparação do mesmo, composição e uso dos mesmos
DK0519327T3 (da)	2000-03-20	N-Acyl-S-(2-hydroxyalkyl) -cysteiner, deres fremstilling samt deres anvendelse som mellemprodukter til fremstilling af synt
AU677868B2 (en)	1997-05-08	New naphthalene derivatives, processes for their preparation and the pharmaceutical compositions which contain them
DE68928174D1 (de)	1997-08-21	Verfahren zur Herstellung von Cephemderivaten
NO982921D0 (no)	1998-06-23	Nye kromenforbindelser, en fremgangsmÕte for deres fremstilling og farmas°ytiske sammensetninger som inneholder disse
ITTO930167A1 (it)	1994-09-10	Derivati dell'acido glutammico ed acido aspartico, procedimento per la loro preparazione e loro uso come farmaci potenzianti la memoria e l'apprendimento.
EP1484322A4 (en)	2008-01-23	PROCESS FOR PRODUCING AN OPTICALLY ACTIVE SULFOXIDE DERIVATIVE
DK1023898T3 (da)	2003-06-10	Cyanoindoler som serotonin-genoptagningsinhibitorer og som 5-HT2c-receptorligander
DE68906572D1 (de)	1993-06-24	Peptide mit inhibitorischer wirkung auf enzymatische systeme, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DK0538477T3 (da)	2002-11-11	Hidtil ukendte cykliske aminophenyleddikesyrederivater, fremstilling deraf og immunreaktonskodulator, der indeholder disse som aktiv bestanddel
DK1061081T3 (da)	2002-08-12	Nye afledede af 7-oxo-2,3,7,14-tetrahydro-1H-benzo[b]pyrano[3,2-h]acridinecarboxylat, fremgangsmåder til fremstilling heraf og farmaceutiske tilberedninger, som indeholder disse
DE60103752D1 (de)	2004-07-15	Verfahren zur herstellung von pyrazolopyridinderivaten
DE69702955D1 (de)	2000-10-05	Bis-Imide Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitung
PT1010694E (pt)	2003-10-31	Derivados espiroimidazolinicos e a sua utilizacao como antagonistas alfa2-adrenergicos e bloqueadores da recaptura de monoaminas
EP0385423A3 (de)	1991-08-14	Verfahren zur Herstellung der optischen Isomeren von 1,4-Dihydro-5-isopropoxy-2-methyl-4-(2-trifluormethylphenyl)-1,6-naphthyridin-3-carbonsäure-ethyl-ester und 1,4-Dihydro-5-isopropoxy-2-methyl-4-(2-trifluormethylphenyl)-1,6-naphthyridin-3-carbonsäure- 2-(N-methyl-N-phenylmethylamino)ethyl ester
NO20023107D0 (no)	2002-06-27	Karboksamid-diazepinderivater, fremstillingsmetode, anvendelse som medisiner, farmasöytiske preparater og anvendelsederav